DSS, Inc. announces a public offering of Common Stock for general corporate purposes, managed by Aegis Capital Corp.
Quiver AI Summary
DSS, Inc., a multinational company listed on the NYSE under the symbol "DSS," has announced a public offering of its Common Stock, the proceeds of which will be used for general corporate and working capital needs. Aegis Capital Corp. is the sole book-running manager for this Offering, which is pending market conditions and follows the effective shelf registration statement previously filed with the SEC. Investors can access the final prospectus supplement and accompanying details through Aegis Capital or the SEC's website. The release contains forward-looking statements regarding the company's future prospects, which carry inherent risks and uncertainty.
Potential Positives
- The company is initiating a public offering of its Common Stock, which could provide significant capital for corporate and working capital needs.
- The offering is being managed by Aegis Capital Corp., indicating a potential level of investor confidence and professional backing.
- DSS, Inc. is operating under an effective shelf registration statement, demonstrating regulatory compliance and preparedness for market activities.
Potential Negatives
- The announcement of a public offering may signal potential dilution of existing shareholders' equity, which could negatively impact stock prices and investor sentiment.
- The offering being subject to market conditions introduces uncertainty, suggesting that the company may be facing challenges in garnering investor confidence.
- The lack of specific details on the intended use of proceeds may raise concerns about the company's strategic direction and financial planning.
FAQ
What is DSS, Inc.'s latest announcement about?
DSS, Inc. announced a public offering of shares of its Common Stock for general corporate needs.
What will the proceeds from the offering be used for?
The net proceeds from the offering will be used for general corporate and working capital needs.
Who is managing the public offering for DSS, Inc.?
Aegis Capital Corp. is the sole book-running manager for the public offering.
How can I access the final prospectus for the offering?
The final prospectus and accompanying prospectus will be available on the SEC’s website and Aegis Capital Corp.
Where is DSS, Inc. listed publicly?
DSS, Inc.'s Common Stock is trading on NYSE American under the ticker symbol "DSS".
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$DSS Hedge Fund Activity
We have seen 7 institutional investors add shares of $DSS stock to their portfolio, and 7 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HRT FINANCIAL LP added 208,481 shares (+inf%) to their portfolio in Q2 2026, for an estimated $123,003
- UBS GROUP AG added 55,077 shares (+11450.5%) to their portfolio in Q2 2026, for an estimated $32,495
- GEODE CAPITAL MANAGEMENT, LLC removed 26,459 shares (-48.7%) from their portfolio in Q2 2026, for an estimated $15,610
- CITADEL ADVISORS LLC added 19,443 shares (+inf%) to their portfolio in Q1 2026, for an estimated $16,137
- DRW SECURITIES, LLC removed 16,033 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $13,307
- XTX TOPCO LTD added 14,323 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,450
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 11,894 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $7,017
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that it has commenced a public offering to offer and sell shares of its Common Stock.
All of the shares of Common Stock are being offered by the Company (the “Offering”).
The Company intends to use the net proceeds from the Offering for general corporate and working capital needs. The Company’s Common Stock is trading on the NYSE American LLC under the symbol “DSS”. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
Aegis Capital Corp. is acting as the sole book-running manager for the offering on a firm commitment basis.
The offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-281974) previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective by the SEC on November 5, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at www.sec.gov . Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at [email protected], or by telephone at +1 (212) 813-1010.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About DSS, Inc.
DSS, Inc. (NYSE American: DSS) is a multinational company operating across multiple business lines including product packaging, biotechnology, commercial lending, and securities and investment management. The Company operates a business model based on developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings. For more information, visit www.dssworld.com .
Forward-Looking Statements
The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.
For investor and media inquiries or additional information, please contact:
Investor Contact:
DSS, Inc.
Investor Relations
[email protected]
+1 (585) 565-2422
